Monoclonal antibody for human hematopoietic glycoproteins...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/37, 195/1.11

G01N 33/53 (2006.01) C07K 16/28 (2006.01) C07K 16/30 (2006.01) C12P 37/00 (2006.01) G01N 33/577 (2006.01) A61K 38/00 (2006.01)

Patent

CA 1257210

ABSTRACT This invention concerns a new monoclonal antibody (mAb) 4C, recognizing a specific antigen, Leu 200, found in human hematopoietic tissues. The monoclonal antibody precipitates a series of glycoproteins (Leu 200) with a molecular weight range of about 190,000 to 230,000 from both T- and B-cell lines. The series of glycoproteins resolves into four discrete glycoprotein bands, the distribution of which varies according to the cell lines. Bands 3 and 4 predominate in a majority of T-cells whereas band 2 predominates in B cells. Thus, a Leu 200 antigen subset distribution is possible with mAb 4C. Bands 1, 2, 3, 4 have apparent molecular weights of 230K, 215K, 205K, and 90K respectively, with differences in their carbohydrate moieties. mAb 4C is a IgG sub two a,kappa immunoglobulin. 4C has potential use in leukemia, hematopoietic cell differentiation and transplantation diagnoses and therapy.

454984

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Monoclonal antibody for human hematopoietic glycoproteins... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibody for human hematopoietic glycoproteins..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody for human hematopoietic glycoproteins... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1180022

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.